Phone:
+1 877 302 8632
Fax:
+1 888 205 9894 (Toll-free)
E-Mail:
orders@antibodies-online.com

Infliximab Products

(Infliximab)

Categories

antibodies-online.com stands for high-quality research products. Search, find and order tools with extensive validation data, images, references. Our scientific customer service is always at your disposal if you have any questions about the selection or application of our products.

Recommended Infliximab Antibodies

Product
Reactivity
Application
Validations
Cat. No.
Quantity
Datasheet
Reactivity Human
Application ELISA
Validations
Cat. No. ABIN7514439
Quantity 40 μg
Datasheet Datasheet

Recommended Infliximab ELISA Kits

Product
Reactivity
Analytical Method
Validations
Cat. No.
Quantity
Datasheet
Reactivity Human, Monkey, Mouse, Rat
Analytical Method Quantitative Sandwich ELISA
Validations
  • (1)
Cat. No. ABIN2862648
Quantity 96 tests
Datasheet Datasheet

Latest Publications for our Infliximab products

Beswick, Rosella, Rosella, Headon, Sparrow, Gibson, van Langenberg: "Exploration of Predictive Biomarkers of Early Infliximab Response in Acute Severe Colitis: A Prospective Pilot Study." in: Journal of Crohn's & colitis, Vol. 12, Issue 3, pp. 289-297, (2018) (PubMed).

Kang, Choi, Choi, Kim, Kim, Lee, Choe et al.: "Subtherapeutic Infliximab Trough Levels and Complete Mucosal Healing Are Associated With Sustained Clinical Remission After Infliximab Cessation in Paediatric-onset Crohn's Disease Patients Treated ..." in: Journal of Crohn's & colitis, Vol. 12, Issue 6, pp. 644-652, (2018) (PubMed).

Fleisher, Ait-Oudhia: "A retrospective examination of the US Food and Drug Administration's clinical pharmacology reviews of oncology biologics for potential use of therapeutic drug monitoring." in: OncoTargets and therapy, Vol. 11, pp. 113-121, (2018) (PubMed).

Ohem, Hradsky, Zarubova, Copova, Bukovska, Prusa, Malickova, Bronsky: "Evaluation of Infliximab Therapy in Children with Crohn's Disease Using Trough Levels Predictors." in: Digestive diseases (Basel, Switzerland), Vol. 36, Issue 1, pp. 40-48, (2018) (PubMed).

Piñero, Juanola, Gutiérrez, Zapater, Giménez, Steinert, Sempere, González-Navajas, Niess, Francés: "IL26 modulates cytokine response and anti-TNF consumption in Crohn's disease patients with bacterial DNA." in: Journal of molecular medicine (Berlin, Germany), Vol. 95, Issue 11, pp. 1227-1236, (2018) (PubMed).

Aomori, Tsuchiya, Suzuki, Jibiki, Otsuka, Ishioka, Kaneko, Takeuchi, Nakamura: "Suppression of infliximab antibody levels by azathioprine in patients with rheumatoid arthritis." in: Die Pharmazie, Vol. 72, Issue 2, pp. 95-97, (2018) (PubMed).

Choi, Kang, Lee, Choe: "Clinical Use of Measuring Trough Levels and Antibodies against Infliximab in Patients with Pediatric Inflammatory Bowel Disease." in: Gut and liver, Vol. 11, Issue 1, pp. 55-61, (2017) (PubMed).

Bálint, Rutka, Végh, Kürti, Gecse, Banai, Bene, Gasztonyi, Kristóf, Lakatos, Miheller, Palatka, Patai, Salamon, Szamosi, Szepes, Tóth, Vincze, Bor, Milassin, Fábián, Nagy, Kolar, Bortlik, Duricova et al.: "Frequency and characteristics of infusion reactions during biosimilar infliximab treatment in inflammatory bowel diseases: results from Central European nationwide cohort. ..." in: Expert opinion on drug safety, Vol. 16, Issue 8, pp. 885-890, (2017) (PubMed).

Kolar, Duricova, Bortlik, Hruba, Machkova, Mitrova, Malickova, Lukas, Lukas: "Infliximab Biosimilar (Remsima™) in Therapy of Inflammatory Bowel Diseases Patients: Experience from One Tertiary Inflammatory Bowel Diseases Centre." in: Digestive diseases (Basel, Switzerland), Vol. 35, Issue 1-2, pp. 91-100, (2017) (PubMed).

Gibellini, De Biasi, Bianchini, Bartolomeo, Fabiano, Manfredini, Ferrari, Albertini, Trenti, Nasi, Pinti, Iannone, Salvarani, Cossarizza, Pellacani: "Anti-TNF-α Drugs Differently Affect the TNFα-sTNFR System and Monocyte Subsets in Patients with Psoriasis." in: PLoS ONE, Vol. 11, Issue 12, pp. e0167757, (2017) (PubMed).

You are here:
Support